Header links

Institute
Research
Talent
Clinical trials
Innovation
Research support
Society

Ensayo abierto de extensión para evaluar la seguridad a largo plazo de ZX008 (clorhidrato de fenfluramina) en solución oral como

Ensayo abierto de extensión para evaluar la seguridad a largo plazo de ZX008 (clorhidrato de fenfluramina) en solución oral como tratamiento adyuvante para convulsiones en pacientes con trastornos infrecuentes de convulsiones tales como encefalopatías epilépticas incluidos el síndrome de Dravet y el síndrome de Lennox-Gastaut

Contact

Protocol code: ZX008-1900
EudraCT code: 2019-001331-31
Pathology: Dravet syndrome or Lennox-Gastaut syndrome
Pharmac: ZX008 (Fenfluramine Hydrochloride)
Promoter: Zogenix
Principal investigator: Toledo Argany, Manuel
Research group: Grup de recerca de l'estat epilèptic i crisis agudes
Service: Neurologia
Phase: Fase III
Recruiting: Closed
Status: Cerrado

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information

The request for information on a research project or clinical trial does not entail inclusion in it.